Benzinga's Top #PreMarket Losers
March 26, 2014 at 08:14 AM EDT
Insmed (NASDAQ: INSM) fell 27.21% to $13.32 in pre-market trading after the company reported that Arikayce did not meet pre-specified ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.